Skip to main content
Clinical Trials/ISRCTN93858860
ISRCTN93858860
Completed
Not Applicable

utrition care and support for the prevention of weight loss in people living with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) (PLWHA)

Valid International (UK)0 sites1,100 target enrollmentJuly 2, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)
Sponsor
Valid International (UK)
Enrollment
1100
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 2, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Valid International (UK)

Eligibility Criteria

Inclusion Criteria

  • The study targets both female and male adults aged between 18 years and 59 years of age, already registered by one HIV positive living group. Participants will be recruited among the positive living group members who fulfill the following criteria:
  • 1\. Confirmed HIV status (HIV positive)
  • 2\. World Health Organization (WHO) stage: no clinical event compatible with stage 3 or 4
  • 3\. CD4 count greater than or equal to 350 cells/µL
  • 4\. Good nutritional status: absence of oedema, mid\-upper arm circumference \[MUAC] greater than 220 mm for women and greater than 230 mm for men, body mass index (BMI) greater than 18\.5 kg/m^2 and no history of weight loss above 5% of usual weight
  • 5\. Physically active (Karnofsky score above 80%)
  • 6\. Permanent resident of the catchment area of the positive living group
  • 7\. Willingness to participate (signed consent form)

Exclusion Criteria

  • 1\. CD4 less than 350 cells/µL
  • 2\. Malnutrition (MUAC less than 220 mm for female and less than 230 mm for male, BMI less than or equal to 18\.5 kg/m^2, presence of bilateral oedema)
  • 4\. Hypertension
  • 5\. Diabetes
  • 6\. Kidney disease
  • 7\. HIV clinical stage 3 or 4
  • 8\. Karnofsky score less than 80%

Outcomes

Primary Outcomes

Not specified

Similar Trials